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INTRODUCTION
•	Chilblain Lupus Erythematosus (CHLE) is a rare form of lupus seen in middleaged females. Also known as “Hutchinson lupus” after Jonathan Hutchinson
(1888).
•	Pathogenesis not well understood-- vasoconstriction or microvascular
injury secondary to exposure to cold? (Contrary to traditional systemic lupus
erythematosus (SLE) in which skin lesions are exacerbated by sun exposure).
•	CHLE has been found to progress to SLE in 20% of cases.

CASE PRESENTATION
•	A 40 year-old Hispanic male presented in November with arthralgias, night sweats,
fevers, weight loss, and violaceous skin lesions in an acral distribution. Medical
history included arthritis and a penile ulcer that developed two months ago.
•	He was urged to go to the ED after an outpatient CBC revealed pancytopenia.
•	A CT scan in the ED showed widespread lymphadenopathy. The patient was
admitted and a lymph node biopsy was performed; however, it showed no signs of
lymphoma.
•	Extensive infectious workup was unrevealing, and penile ulcer biopsy was
negative for organisms.

•	The lesions in CHLE are painful and pruritic violaceous plaques on the palms,
soles, and rarely on the ears, nose, and trunk.

•	Biopsy of a hand lesion showed interface change with a lympho-plasmacytic
infiltrate.

•	CHLE lesions are similar to those found in lupus pernio, erythema nodosum,
cutaneous lesions after embolisation, and idiopathic chilblains. Consequently,
Su et al. have suggested the “Mayo Clinic Diagnostic Criteria”:

•	Anti-dsDNA was negative, but ANA was highly elevated at 1:2,560 with a speckled
pattern. Anti-Smith was also markedly elevated, and complement levels were low.

Major Criteria:

•	Prednisone and hydroxychloroquine were initiated after confirming that G6PD was
normal. The patient’s symptoms and skin lesions improved on this regimen.

•	skin lesions in acral locations induced by exposure to cold
•	evidence of SLE in skin lesions by histopathologic examination or indirect
immunofluorescence

Minor Criteria:
•	the coexistence of SLE or lesions consistent with Discoid LE
•	response to anti-SLE therapy
•	negative results of testing for cryoglobulin and cold agglutinins
Diagnosis of CHLE is confirmed if a patient fulfills both the major and any
one of the minor criteria.

•	The patient was diagnosed with SLE in combination with CHLE.

DISCUSSION
•	Our patient was not the typical age or gender for CHLE; however, he met both of the
major and all of the minor criteria.
•	Treatment of CHLE consists of avoidance of cold weather and treatment with
antibiotics if lesions become secondarily infected. In addition, topical steroids and
calcium channel blockers have been shown to be effective in treating CHLE in 50%
of cases.
•	Antimalarial agents (chloroquine or hydroxychloroquine) are effective in treating SLE
symptoms; however, their effect on CHLE has been debated.
•	In refractory cases, some reports have shown success with mycophenolate mofetil
and full-thickness skin grafts (from an unaffected region).

LEARNING POINTS
•	Chilblain Lupus Erythematosus should be suspected when any patient presents
with violaceous, acral skin lesions that are exacerbated by cold weather and are
associated with other nonspecific systemic symptoms.
•	If left untreated, the disease can progress to SLE and can lead to complications of
kidney failure, pericarditis, vasculitis, increased risk of infections, and worse overall
prognosis.
•	Making the diagnosis of CHLE can be aided by reference to the Mayo Clinic
Diagnostic Criteria.
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